[Pubmed] Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia
Posté : 01 juil. 2026 12:00
Adv Ther. 2026 Jun 30. doi: 10.1007/s12325-026-03663-8. Online ahead of print.
ABSTRACT
INTRODUCTION: Generalized myasthenia gravis (gMG) is a chronic autoimmune disorder that causes muscle weakness. This human factors (HF) validation study aimed to demonstrate that use of a prefilled syringe with needle safety device (PFS-SD) or autoinjector (AI) is safe and effective for patients with gMG, caregivers, and healthcare professionals (HCPs) to administer injectable medication in the intended use environments without preventable use errors.
METHODS: Patients with gMG, caregivers, and HCPs were randomized to the PFS-SD or AI. No training on either device use was provided. The safety and usability of both devices were assessed using simulated use scenarios, knowledge-based questions, and participant feedback.
RESULTS: The simulated use scenario was successfully completed by 94% and 96% of participants using the PFS-SD and AI, respectively, while 90% and 87% of participants, respectively, successfully administered their assigned dose. Device acceptability was reported by 93% and 100% of patient participants for the PFS-SD and AI, respectively.
CONCLUSION: This HF validation study demonstrated that the PFS-SD and AI are safe and effective for use by patients with gMG, caregivers, and HCPs in the intended use environments.
PMID:42380700 | DOI:10.1007/s12325-026-03663-8
Source: https://pubmed.ncbi.nlm.nih.gov/4238070 ... 4&v=2.20.0